USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

v2.5.0

Opposition

Defendant
Name:	Primus Pharmaceuticals, Inc.
Correspondence:	MARIE LAVALLEYE COVINGTON & BURLING LLP ONE CITYCENTER, 850 TENTH STREET NW WASHINGTON, DC 20001 UNITED STATES trademarks@cov.com Phone: 202-662-5439

Serial #:	90271021	Application File	Assignment
Application Status:	ABANDONED - AFTER INTER-PARTES DECISION
Mark:	MODAXXONE

Plaintiff
Name:	Teva Pharmaceutical Industries Ltd.
Correspondence:	THOMAS J. MANGO CANTOR COLBURN LLP 20 CHURCH STREET, 22ND FLOOR HARTFORD, CT 06103 UNITED STATES tmango@cantorcolburn.com, vricci@cantorcolburn.com Phone: 860-286-2929

Serial #:	74348964	Application File	Assignment	Registration #:	1816603
Application Status:	REGISTERED AND RENEWED
Mark:	COPAXONE


Serial #:	85308412	Application File	Assignment	Registration #:	4324952
Application Status:	REGISTERED AND RENEWED
Mark:	COPAXONE CO-PAY SOLUTIONS


Serial #:	85779326	Application File	Assignment	Registration #:	4463886
Application Status:	REGISTERED AND RENEWED
Mark:	COPAXONE ITRACKER


Serial #:	86183826	Application File	Assignment	Registration #:	4786718
Application Status:	SECTION 8-ACCEPTED
Mark:	COPAXONE WEBTRACKER


Serial #:	87646713	Application File	Assignment	Registration #:	5533589
Application Status:	SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Mark:	COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY

Prosecution History
#	Date	History Text	Due Date
9	07/26/2022	TERMINATED
8	07/26/2022	BD DECISION: OPP SUSTAINED
7	07/25/2022	W/DRAW OF APPLICATION
6	12/30/2021	EXTENSION OF TIME GRANTED
5	12/30/2021	P MOT FOR EXT W/ CONSENT
4	12/01/2021	ANSWER
3	10/22/2021	INSTITUTED
2	10/22/2021	NOTICE AND TRIAL DATES SENT; ANSWER DUE:	12/01/2021
1	10/22/2021	FILED AND FEE